Neuropsychiatric lupus: clinical and imaging aspects.
暂无分享,去创建一个
[1] B. Chiang,et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study , 2006, Lupus.
[2] G. Gronseth,et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions , 2002, Neurology.
[3] I. Bruce,et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. , 2007, Arthritis and rheumatism.
[4] S. Ikeda,et al. Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus , 2005, Clinical Rheumatology.
[5] B. Volpe,et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment , 2006, Proceedings of the National Academy of Sciences.
[6] J. Peltola,et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus , 2001, Neurology.
[7] J. Hanly,et al. Brain pathology in systemic lupus erythematosus. , 1992, The Journal of rheumatology.
[8] S. West,et al. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. , 2006, Arthritis and rheumatism.
[9] J. Gómez-Reino,et al. Magnetic resonance imaging of the brain in systemic lupus erythematosus. , 1995, British journal of rheumatology.
[10] S. Pierangeli,et al. Antiphospholipid Antibodies in an in vivo Thrombosis Model in Mice , 1994, Lupus.
[11] J. Ioannidis,et al. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. , 2000, The American journal of medicine.
[12] E. Nitzsche,et al. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: A controlled positron emission tomography study , 1997, European Journal of Nuclear Medicine.
[13] R. Jonsson,et al. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors , 2005, European journal of neurology.
[14] H. Zinger,et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.
[15] M. Ward. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. , 2004, Journal of women's health.
[16] L. Csiba,et al. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension , 2003, Journal of Neurology.
[17] B. Diamond,et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus , 2001, Nature Medicine.
[18] H. Deicher,et al. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus , 1997, Journal of Neurology.
[19] Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings. , 1994, Radiology.
[20] F. Fazekas,et al. Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings. , 1995, Stroke.
[21] G. Hughes,et al. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. , 1995, The American journal of medicine.
[22] C. Millikan,et al. Central nervous system disease in patients with systemic lupus erythematosus , 1992, Neurology.
[23] P. Williams,et al. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus , 2005, Neurology.
[24] N. Abbott,et al. The blood-brain barrier in systemic lupus erythematosus , 2003, Lupus.
[25] C. Sandborg,et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. , 2006, The Journal of rheumatology.
[26] W. Brooks,et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. , 2002, The Journal of rheumatology.
[27] J. Fried,et al. Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage. , 2004, Frontiers in bioscience : a journal and virtual library.
[28] S. Abramson,et al. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. , 1996, Arthritis and rheumatism.
[29] M. Liang,et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. , 2000, The Journal of rheumatology.
[30] J. Satia,et al. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden , 2006, Lupus.
[31] D. Gladman,et al. Mortality related to cerebrovascular disease in systemic lupus erythematosus , 2006, Lupus.
[32] J. Mikdashi,et al. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. , 2004, Rheumatology.